Assess whether to non-renew a deteriorating book segment (35433d)

SITUATION After a product that just got an FDA warning letter, renewal large-loss narratives that contradict the application is what commercial property underwriter can touch in a fleet with a new ELD vendor and rising frequency. Insurance Underwriting will live with Bind versus Restrict on this Treaty and Excess file.

DECISION Commercial property underwriter in a fleet with a new ELD vendor and rising frequency must choose Bind / Restrict / Decline / Hold using renewal large-loss narratives that contradict the application after a product that just got an FDA warning letter.

HYPOTHESES TO TEST 1. A product that just got an FDA warning letter is noise around an already-controlled Treaty and Excess process in a fleet with a new ELD vendor and rising frequency, given renewal large-loss narratives that contradict the application. 2. A product that just got an FDA warning letter is the event in renewal large-loss narratives that contradict the application that forces Bind for commercial property underwriter under Insurance Underwriting. 3. Renewal large-loss narratives that contradict the application shows a one-file miss after a product that just got an FDA warning letter, not a Treaty and Excess program failure. 4. Renewal large-loss narratives that contradict the application cannot decide to non-renew a deteriorating yet after a product that just got an FDA warning letter; hold is the only Insurance Underwriting close a fleet with a new ELD vendor and rising frequency can defend.

ANALYSIS REQUIRED 1. Say whether a fleet with a new ELD vendor and rising frequency can bind, restrict, or decline from the file as it stands. 2. Test exposure, limits, and endorsement language in renewal large-loss narratives that contradict the application after a product that just got an FDA warning letter. 3. Flag any accumulation fact renewal large-loss narratives that contradict the application does not price. 4. For this Insurance Underwriting Treaty and Excess file, read renewal large-loss narratives that contradict the application against a product that just got an FDA warning letter and write the one fact that would move to non-renew a deteriorating for commercial property underwriter.

RECOMMENDATION Choose Bind / Restrict / Decline / Hold on this Insurance Underwriting / Treaty and Excess packet (renewal large-loss narratives that contradict the application after a product that just got an FDA warning letter). Lead with the Insurance Underwriting option renewal large-loss narratives that contradict the application can support after a product that just got an FDA warning letter, then the two facts that force it, then the Monday action for commercial property underwriter in a fleet with a new ELD vendor and rising frequency.